Literature DB >> 8196691

Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin.

K B Polo1, B Jabbari.   

Abstract

Botulinum toxin is now an established treatment for blepharospasm, hemifacial spasm, spasmodic torticollis, and spastic dysphonia. We report the effectiveness of botulinum toxin against painful limb myoclonus of spinal cord origin. The patient, a 16-year-old girl with a pulmonary vascular anomaly, Scimitar syndrome, suffered from an acute spinal cord infarct at age 11. She was left with paralysis of the right leg and bladder dysfunction. Four years after the original insult, she developed "painful cramping" and involuntary movements of the left thigh, which were unresponsive to a wide range of therapeutic trials. The movements were continuous, rhythmic, and confined to the left quadriceps muscles. Electromyographic examination revealed continuous myoclonic discharges. Treatment with botulinum toxin in the left quadriceps muscles resulted in complete cessation of pain and marked reduction in amplitude of the movements, both clinically and electromyographically. This observation indicates the efficacy of botulinum toxin in the treatment of painful spinal myoclonus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8196691     DOI: 10.1002/mds.870090221

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

Review 1.  An update and review of the treatment of myoclonus.

Authors:  Kelly Mills; Zoltan Mari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Myoclonus.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 3.  Botulinum toxin therapy for myofascial pain disorders.

Authors:  Amy M Lang
Journal:  Curr Pain Headache Rep       Date:  2002-10

4.  Evolution of segmental myoclonus during sleep: polygraphic study of two cases.

Authors:  S Bauleo; P De Mitri; G Coccagna
Journal:  Ital J Neurol Sci       Date:  1996-06

Review 5.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 6.  Botulinum Toxin Treatment of Movement Disorders.

Authors:  Yasaman Safarpour; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2018-02-24       Impact factor: 3.598

Review 7.  History of Botulinum Toxin Treatment in Movement Disorders.

Authors:  Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-11-28

Review 8.  Myoclonus: Pathophysiology and Treatment Options.

Authors:  Ariel Levy; Robert Chen
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.972

9.  A Proposal for Botulinum Toxin Type A Injection Into the Temporal Region in Chronic Migraine Headache.

Authors:  Young-Gun Kim; Jung-Hee Bae; Hyeyun Kim; Shuu-Jiun Wang; Seong Taek Kim
Journal:  Toxins (Basel)       Date:  2020-03-28       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.